Formycon AG (LON:0W4N)
London · Delayed Price · Currency is GBP · Price in EUR 22.35
+0.15 (0.66%)
At close: Sep 12, 2025
Formycon AG Market Cap
Formycon AG has a market cap or net worth of 329.23 million as of September 15, 2025. Its market cap has decreased by -57.31% in one year.
Market Cap
329.23M
Enterprise Value
314.47M
Revenue
44.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.35
Market Cap Chart
Since June 23, 2011, Formycon AG's market cap has increased from 29.59M to 329.23M, an increase of 1,012.47%. That is a compound annual growth rate of 18.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 339.13M | -56.38% |
| Dec 30, 2024 | 777.39M | -0.97% |
| Dec 29, 2023 | 784.98M | -32.38% |
| Dec 30, 2022 | 1.16B | 112.32% |
| Dec 30, 2021 | 546.75M | 14.14% |
| Dec 30, 2020 | 479.02M | 75.85% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 182.89B |
| GSK plc | 59.54B |
| Haleon | 31.92B |
| Smith & Nephew | 12.02B |
| ConvaTec Group | 4.70B |
| Hikma Pharmaceuticals | 3.56B |
| HUTCHMED (China) | 2.23B |
| Genus | 1.65B |